[ad_1] Hello and Welcome to the Marketbuzz Podcast on CNBC-TV18. Lets bring you up to speed with everything you need to be aware of before the day’s trading action. GIFT Nifty indicating a start with a positive bias Wall Street rebounds but focus remains on inflation data Pain continues in the broader […]
CNBC-TV18 Morning Call: Wall Street rebounds, GST revision on Namkeen, Cancer drugs and more – CNBC TV18
[ad_1] 1 / 10 US markets saw a rebound on Monday after what has been the worst start to September on record with data going back to as early as 1953. Investors chose to buy Friday’s dip with the Dow Jones ending with gains of nearly 500 points, the S&P 500 gaining 1.1% and the […]
Abbott India, Cipla, Biocon may get some relief from the GST Council: Exclusive – CNBC TV18
[ad_1] The upcoming GST council meeting is likely to provide relief on a slew of cancer drugs, sources with knowledge of the matter told CNBC-TV18. Sources further said that the GST council nominated fitment committee is likely to reduce GST on cancer drugs like Trastuzumab Deruxtecan, Osimertinib, Durvalumab to 5% from the current levels of […]